Loading…
Incannex Healthcare Inc. is projected to rise to $3.52 by 2027, a +20% move from its current price of $2.93. IXHL is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $2.81 | $2.93 | $3.05 | +0.04% |
| Aug 6 | $2.77 | $2.93 | $3.11 | +0.08% |
| Aug 7 | $2.73 | $2.93 | $3.15 | +0.13% |
| Aug 8 | $2.71 | $2.93 | $3.18 | +0.17% |
| Aug 9 | $2.68 | $2.94 | $3.22 | +0.21% |
| Aug 10 | $2.66 | $2.94 | $3.25 | +0.25% |
| Aug 11 | $2.64 | $2.94 | $3.27 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.64 | $2.94 | $3.27 | +0.29% |
| Week 2 | $2.53 | $2.95 | $3.43 | +0.59% |
| Week 3 | $2.45 | $2.96 | $3.56 | +0.89% |
| Week 4 | $2.39 | $2.96 | $3.68 | +1.18% |
| Week 5 | $2.34 | $2.97 | $3.78 | +1.48% |
| Week 6 | $2.29 | $2.98 | $3.88 | +1.78% |
| Week 7 | $2.25 | $2.99 | $3.98 | +2.08% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Incannex Healthcare Inc. (IXHL) is a clinical-stage biopharmaceutical company that engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.
The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder.
It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn’s disease.
Incannex Healthcare Inc. is headquartered in Sydney, Australia.
IXHL is currently priced at $3.12 per share with a market capitalization of $37.33M.
The asset is ranked 4496 by size.
Technically, the sentiment is BEARISH. The RSI(14) is 40, the SMA50 sits at $3.51, and the SMA200 sits at $7.17.
The 30-day range runs from $2.39 to $4.08, with near-term support at $3.12 and resistance at $3.99. Annualized volatility is 80%.
A major floor 24.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.7% away) — a key level to hold.
The nearest ceiling, 36.2% above — a clean break opens room to run.
A major ceiling 67.6% above — clearing it would confirm fresh momentum.
Key IXHL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IXHL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.95 | Sell | $2.96 | Sell |
| MA 10 | $3.04 | Sell | $3.03 | Sell |
| MA 20 | $3.21 | Sell | $3.16 | Sell |
| MA 50 | $3.38 | Sell | $3.45 | Sell |
| MA 100 | $3.53 | Sell | $4.36 | Sell |
| MA 200 | $6.82 | Sell | $8.04 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 36.67 | Neutral |
| Stoch RSI (14) | 22.51 | Neutral |
| CCI (20) | -95.82 | Neutral |
| Williams %R (14) | -90.63 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -8.98 | Sell |
| Bollinger %B (20,2) | 0.24 | Neutral |
| Stochastic %K (14) | 9.37 | Buy |
| TRIX (15) | -0.56 | Sell |
| Awesome (5,34) | -0.41 | Sell |
| Ultimate (7,14,28) | 29.52 | Buy |
| Momentum (10) | -0.23 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 2.88 | Buy |
| ADX (14) | 19.71 | Neutral |
| ATR (14) | 0.08 | Info |
The near-term technical picture is BEARISH, with the RSI(14) at 40.
The price is trading below the SMA50 of $3.51 and well below the SMA200 of $7.17, suggesting downside pressure in the near term.
The stock sits near support at $3.12 and faces resistance at $3.99; the 30-day range is $2.39 to $4.08.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.56 | $2.93 | $4.04 | 0% | Neutral | |
| $2.68 | $3.52 | $4.95 | +20% | Bullish | |
| $2.75 | $3.78 | $5.60 | +29% | Bullish | |
| $2.36 | $3.36 | $5.19 | +15% | Neutral | |
| $2.19 | $3.22 | $5.14 | +10% | Neutral | |
| $2.38 | $3.61 | $5.93 | +23% | Bullish | |
| $2.17 | $3.40 | $5.72 | +16% | Neutral | |
| $2.62 | $4.20 | $7.25 | +44% | Bullish | |
| $3.08 | $5.08 | $8.95 | +73% | Bullish | |
| $2.81 | $4.75 | $8.54 | +62% | Bullish | |
| $3.36 | $6.39 | $12.44 | +118% | Bullish | |
| $4.54 | $10.08 | $22.02 | +244% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.56 | $2.93 | $3.47 | +0.00% |
| September 2026 | $2.37 | $2.85 | $3.54 | -2.84% |
| October 2026 | $2.51 | $3.04 | $3.84 | +6.94% |
| November 2026 | $2.57 | $3.14 | $4.02 | +3.22% |
| December 2026 | $2.54 | $3.13 | $4.04 | -0.48% |
Click any year to see its month-by-month IXHL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Incannex Healthcare Inc.'s 2026 outlook centres on $2.93, within a $2.56 to $4.04 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, IXHL could reach as high as $4.95, with a base case around $3.52 and support toward $2.68 — roughly +20% from $2.93. Buyers look set to stay in control over this stretch.
Expect IXHL to range from $2.75 to $5.60 through 2028. The $3.78 average target implies a +29% move from current prices. That is up +7% on the projected 2027 average. Momentum favours further upside here.
The IXHL price prediction for 2029 points to an average of $3.36 (low $2.36, high $5.19) — a potential gain of +15% on today's $2.93. A consolidation phase looks the most probable path here.
In 2030, IXHL is projected to trade between $2.19 and $5.14, averaging $3.22 — a potential gain of +10% from today's $2.93. That is -4% versus the projected 2029 average. Price action looks broadly range-bound.
Incannex Healthcare Inc.'s 2031 outlook centres on $3.61, within a $2.38 to $5.93 range. That is up +12% on the projected 2030 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, IXHL could reach as high as $5.72, with a base case around $3.40 and support toward $2.17 — roughly +16% from $2.93. Price action looks broadly range-bound.
Expect IXHL to range from $2.62 to $7.25 through 2033. The $4.20 average target implies a +44% move from current prices. That is up +24% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The IXHL price prediction for 2034 points to an average of $5.08 (low $3.08, high $8.95) — a potential gain of +73% on today's $2.93. Momentum favours further upside here.
In 2035, IXHL is projected to trade between $2.81 and $8.54, averaging $4.75 — a potential gain of +62% from today's $2.93. That is -6% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Incannex Healthcare Inc.'s 2040 outlook centres on $6.39, within a $3.36 to $12.44 range. That is up +34% on the projected 2035 average. That marks a +118% change versus current levels. Momentum favours further upside here.
By 2050, IXHL could reach as high as $22.02, with a base case around $10.08 and support toward $4.54 — roughly +244% from $2.93. Buyers look set to stay in control over this stretch.
Investing $1,000 in IXHL today (≈ 341.296928 IXHL) could be worth
$3,441.77
+$2,441.77 (+244%) by 2050 · US Dollar
Based on the average projected IXHL price of $10.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IXHLwould be worth at today's price.
$1,000 invested in IXHL on Jul 31, 2025 (≈ 56.980059 IXHL) would be worth
$166.95
-$833.05 (-83.3%) today · 0.17× · US Dollar
Based on a IXHL entry price of $17.55 vs. today's $2.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.95 | $993.22 | -0.7% |
| 1 month ago | $3.71 | $789.76 | -21.0% |
| 3 months ago | $4.55 | $643.96 | -35.6% |
| 6 months ago | $8.88 | $329.95 | -67.0% |
| 1 year ago | $17.55 | $166.95 | -83.3% |
| All time (4.4y) ago | $1,785.6 | $1.64 | -99.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IXHL forecast.
Our base-case forecast reaches $5.90 around 2040.
Implied market cap at $5.90: $70.59M
The multi-year forecast shows an uptick in IXHL's price trajectory across multiple years. For 2026 the average is $3.12 with a max of $4.38 and a min of $2.56; sentiment Neutral.
Looking further out, 2027 is bullish with an average of $3.82, a max of $5.38, a min of $2.91, and an ROI of 22.4%.
By 2033 the forecast projects an average of $4.62 with a max of $7.98, an ROI of 48.2%, and bullish sentiment. By 2034 the forecast shows an average of $5.45, a max of $9.60, an ROI of 74.7%, and bullish sentiment.
By 2040 the forecast indicates an average of $6.87, a max of $13.37, an ROI of 120.1%, and bullish sentiment. By 2050 the forecast envisions an average of $11.06, a max of $24.16, a min of $4.98, an ROI of 254.5%, and bullish sentiment.
These figures are estimates and not guarantees; actual results may differ.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $2.39, an average of $3.52, and a max of $5.62, with an ROI of 12.8% and sentiment Neutral.
Forecasts show Neutral in 2026 and Bullish in several later years, with ROIs such as 22.4% in 2027 and 25.9% in 2028, up to 254.5% in 2050, but these are estimates and not guarantees.
Yes. The 2050 max forecast is $24.16, with a min of $4.98 and an average of $11.06, and an ROI of 254.5%; sentiment is Bullish.
The 2040 forecast shows an average of $6.87, a min of $3.61, and a max of $13.37, with an ROI of 120.1% and sentiment Bullish.
Current price is $3.12 and market cap is $37.33M; the asset is ranked 4496.
Incannex Healthcare Inc. Community Discussion
0Share your Incannex Healthcare Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.